Patients with systemic lupus erythematosus (SLE) have an increased risk of developing
cardiovascular disease (CVD). Traditional risk factors fail to fully explain all of this increased …

As patients with Systemic Lupus Erythematosus (SLE) live longer due to improved therapies
and preventive measures, death and disability from cardiovascular events are increasing …

Over the past number of years numerous data have been published regarding increased
atherosclerosis in patients with systemic lupus erythematosus (SLE), and it has been shown …

Atherosclerosis is an inflammatory disease characterised by presence of activated immune
competent cells in middle-sized and large arteries and is the major cause of cardiovascular …

Recent discoveries have placed increased emphasis on the immunology of atherosclerotic
cardiovascular disease. Understanding the factors that drive the increased risk for …

Inflammation and dysregulated cholesterol metabolism are key components in the
pathogenesis of atherosclerosis. Premature atherosclerosis is a characteristic feature of …

The accelerated atherosclerosis that occurs in some patients with systemic lupus
erythematosus (SLE) has a complex pathogenesis, including alterations in lipids …

Rheumatic autoimmune diseases, such as rheumatoid arthritis and systemic lupus
erythematosus (SLE), are associated with antibodies to “self” antigens. Persons with …

Atherosclerotic vasculopathy is a multifactorial process causing vessels damage and
cardiovascular diseases, the leading causes of death worldwide. Atherosclerotic plaque is …

Autoimmunity forms the basis of many rheumatological diseases, and may contribute not
only to the classical clinical manifestations but also to the complications. Many of the …